Letter: 5-aminosalicylate maintenance treatment in mild Crohn's disease-authors' reply

被引：0
|
作者：
Atia, Ohad [1 ]
Goren, Idan [2 ,3 ,4 ]
Yanai, Henit [2 ,3 ]
机构：
[1] Hebrew Univ Jerusalem, Juliet Keidan Inst Pediat Gastroenterol Hepatol &, Shaare Zedek Med Ctr, Jerusalem, Israel
[2] Rabin Med Ctr, Div Gastroenterol, Petah Tiqwa, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[4] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 57卷 / 10期
关键词：
D O I：
10.1111/apt.17504
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1184 / 1185
页数：2
相关论文
共 50 条
  • [41] Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease-Authors' reply
    Idalsoaga, Francisco
    Diaz, Luis Antonio
    Ayares, Gustavo
    Cabrera, Daniel
    Chahuan, Javier
    Monrroy, Hugo
    Halawi, Houssam
    Arrese, Marco
    Arab, Juan Pablo
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (08) : 1141 - 1142
  • [42] The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD study
    Burisch, Johan
    Bergemalm, Daniel
    Halfvarson, Jonas
    Domislovic, Viktor
    Krznaric, Zeljko
    Goldis, Adrian
    Dahlerup, Jens F.
    Oksanen, Pia
    Collin, Pekka
    de Castro, Luisa
    Hernandez, Vicent
    Turcan, Svetlana
    Belousova, Elena
    D'Inca, Renata
    Sartini, Alessandro
    Valpiani, Daniela
    Giannotta, Martina
    Misra, Ravi
    Arebi, Naila
    Duricova, Dana
    Bortlik, Martin
    Gatt, Kelly
    Ellul, Pierre
    Pedersen, Natalia
    Kjeldsen, Jens
    Andersen, Karina W.
    Andersen, Vibeke
    Katsanos, Konstantinos H.
    Christodoulou, Dimitrios K.
    Sebastian, Shaji
    Barros, Luisa
    Magro, Fernando
    Midjord, Jongero M. M.
    Nielsen, Kari R.
    Salupere, Riina
    Kievit, Hendrika A. L.
    Kiudelis, Gediminas
    Kupcinskas, Juozas
    Fumery, Mathurin
    Gower-Rousseau, Corinne
    Kaimakliotis, Ioannis P.
    Schwartz, Doron
    Odes, Selwyn
    Lakatos, Laszlo
    Lakatos, Peter L.
    Langholz, Ebbe
    Munkholm, Pia
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (08) : 949 - 960
  • [43] Letter: smoking as a modifiable risk factor for a complicated course in Crohn's disease. Authors' reply
    De Bie, C.
    Ferrante, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (03) : 441 - 441
  • [44] Letter: mucosal healing in ulcerative colitis - higher relevance than in Crohn's disease? Authors' reply
    Laharie, D.
    Filippi, J.
    Roblin, X.
    Nancey, S.
    Peyrin-Biroulet, L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (02) : 208 - 208
  • [45] Letter: the impact of smoking on clinical outcomes after endoscopic dilatation in Crohn's disease - authors' reply
    Gustavsson, A.
    Magnuson, A.
    Blomberg, B.
    Andersson, M.
    Halfvarson, J.
    Tysk, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (04) : 500 - 501
  • [46] Letter: faecal diversion for severe perianal Crohn's disease - practical issues. Authors' reply
    Singh, S.
    Ding, N. S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (10) : 1237 - 1237
  • [47] Letter: association of circulating bile acid concentrations and non-alcoholic fatty liver disease-authors' reply
    Rivera-Andrade, Alvaro
    Petrick, Jessica L.
    Alvarez, Christian S.
    Graubard, Barry I.
    Florio, Andrea A.
    Kroker-Lobos, Maria F.
    Parisi, Dominick
    Freedman, Neal D.
    Lazo, Mariana
    Guallar, Eliseo
    Groopman, John D.
    Ramirez-Zea, Manuel
    McGlynn, Katherine A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (02) : 374 - 375
  • [48] Letter: Meta-Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease-Authors' Reply
    Carbery, Isabel
    Todd, Oliver
    Selinger, Christian P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (04) : 746 - 747
  • [49] Exposure to hookworms in patients with Crohn's disease: authors' reply
    Ramakrishna, B. S.
    Binder, H. J.
    Subramanian, V.
    Pugazhendhi, S.
    Kabeerdoss, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (10) : 1250 - 1250
  • [50] Mortality in patients hospitalised with Crohn's disease: authors' reply
    Kennedy, N.
    Bauer, J.
    Clark, D.
    Crowe, A.
    Knight, A.
    Nicholls, J.
    Satsangi, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (03) : 397 - 398
12345